Colgate-Palmolive (CL) Tops Q3 EPS by 4c, Beats on Revenue; Offers Guidance
Get Alerts CL Hot Sheet
Join SI Premium – FREE
Colgate-Palmolive (NYSE: CL) reported Q3 EPS of $0.97, $0.04 better than the analyst estimate of $0.93. Revenue for the quarter came in at $5.37 billion versus the consensus estimate of $5.34 billion.
Colgate-Palmolive outlook FY net sales growth 4-5%.
For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Ovintiv Inc. (OVV) Tops Q3 EPS by 3c
- Comscore (SCOR) Misses Q3 EPS by 446c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share